Source: PR-INSIDE.COM

Press Release: Everist Genomics : Now Available: Everist Genomics, Inc. - Medical Equipment - Deals and Alliances Profile

(PR-inside.com) Everist Genomics, Inc. is a personalized medicine company. The company develops and commercializes medical diagnostic, prognostics and therapeutic selection technologies. Its lead product is the AngioDefender cardiovascular disease (CVD) diagnostic system, a non invasive device that combines sensor technology with a software algorithm to help healthcare providers assess the presence of early stage CVD and atherosclerosis. Its products are used in early diagnosis of atherosclerosis and cardiovascular disease. The company offers products in the disease areas, such as cancer, cardiovascular disease, and metabolic disease. The company markets its products across India, Canada, the UK, and the UAE. Everist Health is ..

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Thomas S. Everist's photo - CEO of Everist Genomics

CEO

Thomas S. Everist

CEO Approval Rating

68/100

Read more